MCK vs PATH · P/E 20, rev $403.43B vs P/E 19, rev $1.61B
McKesson Corporation (MCK) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
MCK currently screens at market cap $91.30B and trailing P/E 20.3. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the MCK and PATH stock pages for the full models.
Not investment advice.